TY - JOUR
T1 - Improving outcomes of hypoglossal nerve stimulation therapy
T2 - current practice, future directions, and research gaps. Proceedings of the 2019 International Sleep Surgery Society Research Forum
AU - Suurna, Maria V.
AU - Jacobowitz, Ofer
AU - Chang, Jolie
AU - Koutsourelakis, Ioannis
AU - Smith, David
AU - Alkan, Uri
AU - D'Agostino, Mark
AU - Boon, Maurits
AU - Heiser, Clemens
AU - Hoff, Paul
AU - Huntley, Colin
AU - Kent, David
AU - Kominsky, Alan
AU - Lewis, Richard
AU - Maurer, Joachim T.
AU - Ravesloot, Madeline J.
AU - Soose, Ryan
AU - Steffen, Armin
AU - Weaver, Edward M.
AU - Williams, Amy M.
AU - Woodson, Tucker
AU - Yaremchuk, Kathleen
AU - Ishman, Stacey L.
N1 - Publisher Copyright:
© 2021 American Academy of Sleep Medicine. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Hypoglossal nerve stimulation (HGNS) has evolved as a novel and effective therapy for patients with moderate-to-severe obstructive sleep apnea. Despite positive published outcomes of HGNS, there exist uncertainties regarding proper patient selection, surgical technique, and the reporting of outcomes and individual factors that impact therapy effectiveness. According to current guidelines, this therapy is indicated for select patients, and recommendations are based on the Stimulation Therapy for Apnea Reduction or STAR trial. Ongoing research and physician experiences continuously improve methods to optimize the therapy. An understanding of the way in which airway anatomy, obstructive sleep apnea phenotypes, individual health status, psychological conditions, and comorbid sleep disorders influence the effectiveness of HGNS is essential to improve outcomes and expand therapy indications. This article presents discussions on current evidence, future directions, and research gaps for HGNS therapy from the 10th International Surgical Sleep Society expert research panel.
AB - Hypoglossal nerve stimulation (HGNS) has evolved as a novel and effective therapy for patients with moderate-to-severe obstructive sleep apnea. Despite positive published outcomes of HGNS, there exist uncertainties regarding proper patient selection, surgical technique, and the reporting of outcomes and individual factors that impact therapy effectiveness. According to current guidelines, this therapy is indicated for select patients, and recommendations are based on the Stimulation Therapy for Apnea Reduction or STAR trial. Ongoing research and physician experiences continuously improve methods to optimize the therapy. An understanding of the way in which airway anatomy, obstructive sleep apnea phenotypes, individual health status, psychological conditions, and comorbid sleep disorders influence the effectiveness of HGNS is essential to improve outcomes and expand therapy indications. This article presents discussions on current evidence, future directions, and research gaps for HGNS therapy from the 10th International Surgical Sleep Society expert research panel.
KW - OSA
KW - OSA treatment
KW - hypoglossal nerve stimulation
KW - neurostimulation
KW - sleep apnea
KW - sleep surgery outcomes
KW - upper airway stimulation
KW - upper airway surgery
UR - http://www.scopus.com/inward/record.url?scp=85122489448&partnerID=8YFLogxK
U2 - 10.5664/jcsm.9542
DO - 10.5664/jcsm.9542
M3 - Article
C2 - 34279214
AN - SCOPUS:85122489448
SN - 1550-9389
VL - 17
SP - 2477
EP - 2487
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 12
ER -